183 results
10-Q
2023 Q3
EX-10.1
TXMD
TherapeuticsMD Inc
Quarterly report
14 Nov 23
12:00am
10-K
2022 FY
EX-10.46
TXMD
TherapeuticsMD Inc
Annual report
7 Apr 23
4:46pm
10-K
2022 FY
EX-10.48
TXMD
TherapeuticsMD Inc
Annual report
7 Apr 23
4:46pm
10-K
2022 FY
EX-10.45
TXMD
TherapeuticsMD Inc
Annual report
7 Apr 23
4:46pm
10-K
2022 FY
EX-10.47
TXMD
TherapeuticsMD Inc
Annual report
7 Apr 23
4:46pm
8-K
EX-10.1
smn5q472fwyfk
27 Feb 23
Departure of Directors or Certain Officers
4:27pm
8-K
EX-10.2
z0x6lu
27 Feb 23
Departure of Directors or Certain Officers
4:27pm
8-K
EX-10.1
tsjgzyagoo8xrt5muww
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-10.2
jv35hemn
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-10.1
qj1dhmw07vlv1hytv0w
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.2
i0qzqa6 qxq
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
ysqd4jh0l da
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
xfrgf g6mbjcrrh4g6bd
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
yuw7i
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-10.1
wch9xncb9eqkespeiol
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-10.3
55f 2491jr647n0ies
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am